Sysmex Nederland
Menu

Breast Cancer is a challenge best faced together

One in eight women in Europe will develop breast cancer at some stage in her life. Yet closer cooperation between specialists, new diagnostics and therapies have improved survival rates significantly1,2 as well as Patients’ quality of life.3-5 

Sysmex is playing a significant role in these improvements for you as a clinician, and your patients.

  • Eliminate concerns regarding guidewire or radioactive makers for impalpable lesion localisation by using the Sentimag® / Magseed® system for true convenience for you and your patients.
  • Your patients can benefit from tissue-saving operations and fewer long-term effects thanks to the sentinel lymph node biopsy (SNLB) concept.
  • You no longer need radioactive markers to detect sentinel lymph nodes as the Sentimag® / Sienna+® system detects them magnetically.
  • Get reliable findings based on whole nodes – not just slices – using OSNA’s molecular lymph node analysis; also inter-operatively. It’s shown to help deliver individualised therapy decisions too.
  • Reduce your patients’ limitations in everyday life using modern breast cancer management even with the most essential, systemic cancer treatment.

Literature

  1. SEER Stat Fact Sheets: Female Breast Cancer. seer.cancer.gov/statfacts/html/breast.html (accessed Sep. 20, 2016).
  2. Allemani C. et al. (2015): Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887
    patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 385:977-1010.
  3. Kirshbaum M.N. et al.(2016): Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis. Eur. J. Cancer Care, advance online publication, doi: 10.1111/ecc.12577.
  4. Hamer J. et al.(2016): Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Support Care Cancer, advance online publication, doi:10.1007/s00520-016-3417-6.
  5. Pinto A.C. et al.(2011): Improving quality of life after breast cancer: dealing with symptoms. Maturitas, 70(4):343-348.

Endomag®, Sentimag®, Magseed® and Sienna+® are registered European Community Trademarks of Endomagnetics Ltd. www.endomag.com.

Watch our videos

Molecular intraoperative staging with OSNA

Molecular intraoperative staging with OSNA

Magseed placement in radiology

Magseed placement in radiology

Lesion localisation with Magseed in surgery

Lesion localisation with Magseed in surgery

Copyright © Sysmex Europe GmbH. All rights reserved.
Personaliseer uw ervaring

Wij gebruiken cookies zodat u onze website optimaal kunt benutten en wij onze communicatie met u kunnen verbeteren. Wij baseren ons daarbij op uw selectie en gebruiken alleen de gegevens waarvoor u ons toestemming geeft.

* Kan de weergave van content en de gebruikerservaring beperken.
Details over cookies
Noodzakelijke cookies
Deze cookies helpen om onze website bruikbaar te maken door basisfuncties zoals paginanavigatie en toegang tot beveiligde delen van onze website te ondersteunen. Zonder deze cookies kan onze website niet goed functioneren.
Statistiekcookies
Deze cookies registreren hoe bezoekers interactief met onze website omgaan door anoniem informatie te verzamelen. Met deze informatie kunnen wij onze dienstverlening continu verbeteren.
Marketingcookies
Worden gebruikt om bezoekers op webpagina's te volgen. De bedoeling is om advertenties te tonen die relevant en aantrekkelijk zijn voor de individuele gebruiker en daarmee waardevol voor uitgevers en externe adverteerders.